ROBIO-EX, the First Robotic Assisted Pain Management Technology was introduced by BGS Global Hospitals in Karnataka. Dr R Madhan Kumar of BGS Global Hospitals said, “With the introduction of robotics in the field of Interventional Pain Management, it will hugely benefit the patients suffering from chronic pain due to medical conditions like cancer, knee pain, neck pain, low back pain and chronic headaches etc. Interventional pain management uses techniques, such as injections and radiofrequency rhizotomy, to directly address the source of the pain. The treatment plan is tailored to the condition and degree of pain. Robotic guided interventional pain management has been weighed heavily than the conventional methods. The accuracy, safety and duration of the procedure are highly commendable using robot.”
Vice Chairman & Chief Neurosurgeon of BGS Global Hospitals, Dr Venkatramanaa NK said, “Chronic pain could be due to malignant and non-malignant conditions and the treatment for the chronic pain is highly challenging and complex. Robotics is the new form of quality treatment in the field of pain which benefits many patients”.
Other News
High-Value Medical Equipment: Customs Exemptions
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC – Special Expert Committee
The Central Drugs Standard Control Organization (CDSCO) has recently published an article titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read More
